Current filters:


1 to 9 of 96328 results

Lilly to drop Ph III tabalumab trial in lupus due to poor efficacy


US pharma major Eli Lilly has said it will discontinue development of tabalumab, which is being studied…

Anti-Arthritics/RheumaticsEli LillyImmunologicalsPharmaceuticalResearchtabalumab

Incyte earns $60 million milestone on European reimbursement for Jakavi


US biopharma company Incyte says that it has earned a $60 million milestone payment from Swiss pharma…


Supernus sues Actavis for Trokendi XR patents infringement


USA-based specialty drug firm Supernus Pharmaceuticals says it has sued generic drugmaker Actavis and…

ActavisGenericsLegalNeurologicalPatentsSupernus PharmaceuticalsTrokendi XRUSA

Denmark’s Forward Pharma plans IPO


Denmark-based Forward Pharma A/S today announced it has commenced an underwritten initial public offering…

BiotechnologyFinancialForward PharmaImmunologicals

Intrexon and Amneal in second product collaboration


US synthetic biology specialist Intrexon and privately-held generics drugmaker Amneal Pharmaceuticals…

Amneal PharmaceuticalsGenericsIntrexonLicensingProduction

Oxford BioTherapeutics and Berlin Chemie/Menarini update on $1 billion oncology investment alliance


UK biotech firm Oxford BioTherapeutics and family-owned Italian Berlin Chemie/Menarini Group have designated…

BiotechnologyMenariniOncologyOxford BioTherapeuticsResearch

Report: HER2-positive breast cancer market could treble in USA by 2023

Report: HER2-positive breast cancer market could treble in USA by 2023


The US treatment market for human epidermal growth factor receptor type 2 (HER2)-positive breast cancer…

HerceptinMarkets & MarketingOncologyPharmaceuticalRocheUSA

Relmada appoints Julie Chen as Director of Finance and Operations


US pain therapeutic specialists Relmada Therapeutics has appointed Julie Chen as its Director of Finance…

AnalgesiaBoardroomPharmaceuticalRelmada TherapeuticsUSA

1 to 9 of 96328 results

Back to top